DK2684888T3 - New crosslinked peptides containing non-peptide crosslinked structure, process for synthesizing crosslinked peptides and new organic compound used in the process - Google Patents
New crosslinked peptides containing non-peptide crosslinked structure, process for synthesizing crosslinked peptides and new organic compound used in the process Download PDFInfo
- Publication number
- DK2684888T3 DK2684888T3 DK12755137.2T DK12755137T DK2684888T3 DK 2684888 T3 DK2684888 T3 DK 2684888T3 DK 12755137 T DK12755137 T DK 12755137T DK 2684888 T3 DK2684888 T3 DK 2684888T3
- Authority
- DK
- Denmark
- Prior art keywords
- crosslinked
- new
- organic compound
- synthesizing
- compound used
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011052107 | 2011-03-09 | ||
PCT/JP2012/054895 WO2012121057A1 (en) | 2011-03-09 | 2012-02-28 | Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2684888T3 true DK2684888T3 (en) | 2019-08-19 |
Family
ID=46798025
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK12755137.2T DK2684888T3 (en) | 2011-03-09 | 2012-02-28 | New crosslinked peptides containing non-peptide crosslinked structure, process for synthesizing crosslinked peptides and new organic compound used in the process |
Country Status (7)
Country | Link |
---|---|
US (2) | US9376467B2 (en) |
EP (1) | EP2684888B1 (en) |
JP (1) | JP6150726B2 (en) |
CN (1) | CN103415530A (en) |
DK (1) | DK2684888T3 (en) |
ES (1) | ES2742299T3 (en) |
WO (1) | WO2012121057A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2677045C (en) | 2007-01-31 | 2016-10-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
CA2682174C (en) | 2007-03-28 | 2021-04-06 | President And Fellows Of Harvard College | Stitched polypeptides |
WO2012021876A2 (en) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
CN108929375A (en) | 2011-10-18 | 2018-12-04 | 爱勒让治疗公司 | Peptidomimetic macrocyclic compound |
ES2817877T3 (en) | 2012-02-15 | 2021-04-08 | Aileron Therapeutics Inc | Peptidomimetic macrocycles |
WO2013123267A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
JP6526563B2 (en) | 2012-11-01 | 2019-06-05 | エイルロン セラピューティクス,インコーポレイテッド | Disubstituted amino acids and methods for their preparation and use |
WO2016037053A1 (en) | 2014-09-05 | 2016-03-10 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
BR112017005736A2 (en) | 2014-09-24 | 2017-12-12 | Aileron Therapeutics Inc | peptidomimetic macrocycles and formulations thereof |
SG10201902594QA (en) | 2014-09-24 | 2019-04-29 | Aileron Therapeutics Inc | Peptidomimetic macrocycles and uses thereof |
CA2979847A1 (en) | 2015-03-20 | 2016-09-29 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
CN108368161A (en) | 2015-09-10 | 2018-08-03 | 艾瑞朗医疗公司 | Peptidomimetic macrocyclic compound as MCL-1 conditioning agents |
CN108474047B (en) * | 2016-01-29 | 2021-03-23 | 西铁城时计株式会社 | Detection solution for detecting whether leather is treated with 6-valent chromium reducing compound |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH08501066A (en) | 1992-06-02 | 1996-02-06 | ハフスルンド・ニユコメド・アクシエセルカペト | Peptide compounds |
SE9302247L (en) | 1993-06-30 | 1994-12-31 | Cultor Oy | New crosslinker and its use |
IL109943A (en) * | 1994-06-08 | 2006-08-01 | Develogen Israel Ltd | Conformationally constrained backbone cyclized peptide analogs |
SE9604341D0 (en) | 1996-11-26 | 1996-11-26 | Ferring Bv | Hepta-peptide oxytocin analogue |
US6265535B1 (en) | 1997-05-30 | 2001-07-24 | The Trustees Of The University Of Pennsylvania | Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses |
US6608027B1 (en) | 1999-04-06 | 2003-08-19 | Boehringer Ingelheim (Canada) Ltd | Macrocyclic peptides active against the hepatitis C virus |
CA2380009A1 (en) * | 1999-07-28 | 2001-02-08 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclastogenesis |
US6682739B1 (en) | 1999-07-28 | 2004-01-27 | The Trustees Of The University Of Pennsylvania | Methods of inhibiting osteoclastogenesis |
JP4680362B2 (en) | 2000-09-22 | 2011-05-11 | 株式会社石井工作研究所 | Electronic component manufacturing method and manufacturing apparatus |
JP2004059509A (en) | 2002-07-30 | 2004-02-26 | Nokodai Tlo Kk | Amino acid reagent for liquid phase peptide synthesis |
KR20060085248A (en) | 2003-09-26 | 2006-07-26 | 쉐링 코포레이션 | Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
US20110150835A1 (en) | 2003-09-26 | 2011-06-23 | Schering Corporation | Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease |
CN107090025A (en) | 2003-11-05 | 2017-08-25 | 达纳-法伯癌症研究所股份有限公司 | Stable alpha helical peptides and application thereof |
DE102004032608A1 (en) * | 2004-07-05 | 2006-02-16 | United Mobile Holding Ltd. | Callback procedure in a communication system |
AU2006293180A1 (en) | 2005-09-20 | 2007-03-29 | Jitsubo Co., Ltd. | Carrier for separation, method for separation of compound, and method for synthesis of peptide using the carrier |
CN101405240B (en) | 2006-03-24 | 2012-07-25 | 日商·Jitsubo株式会社 | Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
WO2008033505A1 (en) | 2006-09-13 | 2008-03-20 | University Of South Florida | Biocomposite for artificial tissue design |
JP2010119382A (en) * | 2008-10-23 | 2010-06-03 | Osaka Univ | Method for fluorescently labeling protein |
US8569453B2 (en) | 2009-03-12 | 2013-10-29 | Ajinomoto Co., Inc. | Fluorene compound |
JP5768712B2 (en) | 2009-03-30 | 2015-08-26 | 味の素株式会社 | Diphenylmethane compounds |
WO2010147666A1 (en) * | 2009-06-19 | 2010-12-23 | Memorial Sloan-Kettering Cancer Center | Compounds useful as carbonic anhydrase modulators and uses thereof |
WO2011008260A2 (en) | 2009-07-13 | 2011-01-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
JP2014101274A (en) * | 2011-03-09 | 2014-06-05 | Jitsubo Co Ltd | Pharmaceutical composition using mimic peptide of tnf receptor loop peptide comprising new crosslinked structure |
-
2012
- 2012-02-28 WO PCT/JP2012/054895 patent/WO2012121057A1/en active Application Filing
- 2012-02-28 ES ES12755137T patent/ES2742299T3/en active Active
- 2012-02-28 JP JP2013503461A patent/JP6150726B2/en active Active
- 2012-02-28 DK DK12755137.2T patent/DK2684888T3/en active
- 2012-02-28 CN CN2012800123922A patent/CN103415530A/en active Pending
- 2012-02-28 US US14/004,058 patent/US9376467B2/en active Active
- 2012-02-28 EP EP12755137.2A patent/EP2684888B1/en active Active
-
2016
- 2016-05-17 US US15/156,718 patent/US10633418B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20130345393A1 (en) | 2013-12-26 |
JP6150726B2 (en) | 2017-06-21 |
US10633418B2 (en) | 2020-04-28 |
EP2684888A1 (en) | 2014-01-15 |
US9376467B2 (en) | 2016-06-28 |
EP2684888B1 (en) | 2019-05-15 |
EP2684888A4 (en) | 2015-01-21 |
CN103415530A (en) | 2013-11-27 |
ES2742299T3 (en) | 2020-02-13 |
US20160333052A1 (en) | 2016-11-17 |
WO2012121057A1 (en) | 2012-09-13 |
JPWO2012121057A1 (en) | 2014-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2684888T3 (en) | New crosslinked peptides containing non-peptide crosslinked structure, process for synthesizing crosslinked peptides and new organic compound used in the process | |
DK3425805T3 (en) | Sample array encoding for low latency | |
BR112012018101A2 (en) | apparatus, and method. | |
DK2859017T3 (en) | ANTIBODIES INCLUDING PLACE-SPECIFIC NON-NATURAL AMINO ACID, PROCEDURE FOR MANUFACTURING ITS AND METHODS OF USE THEREOF | |
DK2591006T3 (en) | PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE BY USING THEREOF | |
DK3223284T3 (en) | PROCESS FOR CREATING AND MAINTAINING THE HIGHLIGHTS FRC | |
IT1403054B1 (en) | BOTTLE. | |
DK3070945T3 (en) | DEVICE FOR PREDICTIVE PICTURE DECODING, PICTURE PREVIEW DECODING PROCEDURE | |
DK2794907T3 (en) | METHODS AND MATERIALS FOR ASSESSING HETEROZYGOSITY LOSS | |
DK3053932T3 (en) | Hitherto UNKNOWN CTLA4-IG-IMMUNOADHESINER | |
BR112014015994A2 (en) | process. | |
DK3421597T3 (en) | CHRYSOSPORIUM LUCKNOWENSE PROTEIN PRODUCTION SYSTEM | |
DK2677029T3 (en) | Methods for producing proteolytically processed polypeptides | |
BR112012016424A2 (en) | apparatus, and method. | |
DK2310501T3 (en) | New regulatory elements | |
DK3388687T3 (en) | VOLTAGE APPLICATION DEVICE, ROTATING DEVICE AND VOLTAGE APPLICATION PROCEDURE | |
DK3435087T3 (en) | UNKNOWN PROCESSES FOR PROTEIN EVOLUTION | |
DK3001686T3 (en) | DEVICE, PROCEDURE AND PROGRAM FOR BIPREPREDIC IMAGE DECODING | |
DK2618842T3 (en) | HOWEVER, UNKNOWN IMMUNICATIVE PROCEDURE | |
IT1398984B1 (en) | PERFECT LOCK-DOOR DEVICE. | |
CO6980642A2 (en) | Transportable Reformer | |
DK2650049T3 (en) | Hydrogen treatment catalyst and process for its preparation | |
DK2390884T3 (en) | Superconducting magnetizer | |
BR112012024474A2 (en) | process | |
DK2683371T3 (en) | COMPOUNDS AND METHODS FOR IMPROVING THE DETERIORED ENDOGEN FIBRINOLYSE USING HISTONDEACETYLASE INHIBITORS |